" /> Cudarolimab - CISMeF





Preferred Label : Cudarolimab;

NCIt synonyms : Anti-OX40 Monoclonal Antibody IBI101;

NCIt definition : An agonistic fully human anti-OX40 (tumor necrosis factor receptor superfamily member 4; TNFRSF4; CD134; OX40L receptor) with potential immune checkpoint inhibitory and antineoplastic activities. Upon administration, cudarolimab selectively binds to and activates OX40. Receptor activation induces proliferation of memory and effector T-lymphocytes and results in a T-cell-mediated immune response against tumor cells, which leads to tumor cell lysis. OX40, a cell surface glycoprotein and member of the tumor necrosis factor receptor superfamily (TNFRSF), is expressed on T-lymphocytes and provides a co-stimulatory signal that promotes both the proliferation and survival of activated T-cells.;

UNII : DT958C4NWR;

CAS number : 2244739-29-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2244739-29-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : IBI 101; IBI-101;

NCI Metathesaurus CUI : CL938052;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.